$Syndax Pharmaceuticals (SNDX.US)$Syndax Pharmaceuticals Says FDA Grants Priority Review to New Drug Application for Acute Leukemia Treatment MT Newswires· 1 min ago Syndax Pharmaceuticals (SNDX) said late Tuesday the US Food and Drug Administration has granted priority review for the company's new drug application for revumenib to treat relapsed or refractory acute leukemia, a type of cancer. The company said the filing was assigned a prescription drug user fee act target action date of S...
Syndax Pharmaceuticals股票討論
$再生元製藥公司 (REGN.US)$ : 🤔
⇨ 林沃塞爾塔馬布
‣ 多發性骨髓瘤
‣ 截止日期:8/22/24(一頁)
🗓️ 上週的 PDUFA:
$吉利德科學 (GILD.US)$ :8 月 14 日獲批准 🎉
⇨ 利夫德爾齊(塞拉德爾帕爾)
‣ 原發性膽汁性膽管炎(PBC)
‣ 截止日期:8/14/24(即時)
$Ascendis Pharma A/S (ASND.US)$ :8 月 12 日獲批准 🎉
⇨ 約維帕特(帕洛佩特里帕蒂德)
‣ 副甲狀腺功能下
‣ 截止日期:8/14/24(即時)
$Syndax Pharmaceuticals (SNDX.US)$ & $因塞特 (INCY.US)$ :8 月 14 日獲批准 🎉
⇨ 尼克特...
5分鐘前
因塞特和Syndax宣布美國FDA批准Niktimvo™(Axatilimab-Csfr)用於治療慢性移植物抗宿主病(Gvhd)
$Humacyte (HUMA.US)$ : 🤔
⇨ 人類非細胞血管(HAV)™
‣ 血管創傷
‣ 截止日期:8/10/24(一頁)
🗓️ 上週的廣告通訊和 PDUFA:
$Zevra Therapeutics (ZVRA.US)$ :優惠的廣告通訊 👍
🗳️ 11-5 票贊成
⇨ 阿里莫克洛莫
‣ 尼曼-皮克病 C 型
‣ 廣告通訊:8 月 2 日 24 日(不同時間)
$Adaptimmune Therapeutics (ADAP.US)$ :已核准 🎉
⇨ 泰塞拉(非氨基自體細胞)
‣ 關節性肉瘤
‣ 版本:8/4/24(一頁)
$葛蘭素史克 (GSK.US)$ :已核准 🎉
⇨ 詹珀利
‣ 子宮內膜...
MT Newswires· 1 min ago
Syndax Pharmaceuticals (SNDX) said late Tuesday the US Food and Drug Administration has granted priority review for the company's new drug application for revumenib to treat relapsed or refractory acute leukemia, a type of cancer.
The company said the filing was assigned a prescription drug user fee act target action date of S...
3 分鐘前,上午 7 點前
通過 PR 新聞網
暫無評論